Tom Wilton
Corporate Officer/Principal bei CARISMA THERAPEUTICS, INC.
Profil
Tom Wilton is currently the Chief Business Officer at LogicBio Therapeutics, Inc. and Carisma Therapeutics, Inc. He is a graduate of Brunel University, the University of Leeds, and the University of London.
Aktive Positionen von Tom Wilton
Unternehmen | Position | Beginn |
---|---|---|
CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.09.2019 |
LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Tom Wilton
Brunel University | Graduate Degree |
University of Leeds | Graduate Degree |
University of London | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CARISMA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
LogicBio Therapeutics, Inc.
LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |